Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Cerebral venous drainage in multiple sclerosis
ISRCTN ISRCTN75786983
ClinicalTrials.gov identifier
Public title Cerebral venous drainage in multiple sclerosis
Scientific title Cerebral venous drainage in multiple sclerosis: protocol for a blinded, age-sex matched cross-sectional ultrasound study
Acronym N/A
Serial number at source 11/LO/1139
Study hypothesis There will be statistically and clinically significant differences in cerebral venous outflow disturbance between multiple sclerosis patients and healthy controls.
Lay summary Lay summary under review
Ethics approval UK National Research Ethics Board approved on 15th August 2011, ref: 11/LO/1139
Study design Sonographer blinded age-sex healthy control matched cross-sectional ultrasound study
Countries of recruitment United Kingdom
Disease/condition/study domain Multiple sclerosis
Participants - inclusion criteria 1. 18 years of age or greater
2. Informed consent
3. Cases: multiple sclerosis by McDonald criteria with estimated disease severity score < 6, any disease pattern
4. Controls: no other relevant health condition
5. Ability to perform Valsalva manoeuvre
6. Stable disease for one month pre-recruitment
Participants - exclusion criteria 1. Concurrent enrolment in multiple sclerosis drug trial
2. Concurrent masking neurological disease
3. Pregnancy
4. Inability to lie supine
5. Intercurrent infection
6. Superior vena cava obstruction
7. Tricuspid regurgitation
8. Right heart failure
9. Vasculitis
10. Treatment with venodilators (e.g. nitrates)
11. Head and neck surgery or radiotherapy
12. Previous central venous catheterisation
13. Previous central venous thrombosis
14. Thrombophilia
15. Arrhythmia on baseline electrocardiogram (ECG)
16. Postural systolic drop of >30mmHg on standing
17. Steroid treatment within one month
18. Pulmonary hypertension
19. Malignancy
Anticipated start date 01/11/2011
Anticipated end date 01/11/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 60
Interventions All participants will undergo a lying and standing blood pressure measurement and an electrocardiogram (heart tracing) on entry to the study.

All participants will then undergo a one hour ultrasound examination of the neck, comprising thirty minutes lying flat and thirty minutes sitting upright.

At the end of the examination the images will be stored for future analysis at a another time point, i.e. results will not be disclosed to the participant.

Any willing participants will be invited back for a future rescan in 2 weeks by one of the same sonographers. No further follow up is required for this study.
Primary outcome measure(s) 1. Reflux (>0.88s) in the internal jugular (IJV) and vertebral veins (VVs) using triplex mode
2. High resolution B-mode evidence of IJV stenosis in transverse orientation (>50% cross-sectional area diameter reduction) with and without Valsalva
3. Undetectable Doppler flow in the IJVs and VVs using colour and Spectral Doppler
4. Cross-sectional area change of the IJV from the supine to sitting position
Secondary outcome measure(s) Inter and intra sonographer reproducibility
Sources of funding 1. The Royal College of Surgeons of England (UK)
2. The Venous Forum at the Royal Society of Medicine (UK)
Trial website
Publications
Contact name Dr  Richard  Nicholas
  Address MS Day Unit
4 North
Charing Cross Hospital
  City/town London
  Zip/Postcode W6 8RF
  Country United Kingdom
Sponsor Imperial College London (UK)
  Address Joint Research Office
Exhibition Road
  City/town London
  Zip/Postcode SW7 2AZ
  Country United Kingdom
Date applied 17/10/2011
Last edited 14/11/2011
Date ISRCTN assigned 14/11/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central